UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 612

Sortiert nach

A fully packaged self-powered sensor based on near-field electrospun arrays of poly(vinylidene fluoride) nano/micro fibers

Express polymer letters, 2018-02, Vol.12 (2), p.136-145

2018

Volltextzugriff (PDF)

A fully encapsulated piezoelectric–triboelectric hybrid nanogenerator for energy harvesting from biomechanical and environmental sources

Express polymer letters, 2019-06, Vol.13 (6), p.533-542

2019

Volltextzugriff (PDF)

Anti‐CD22 and anti‐CD79b antibody‐drug conjugates preferentially target proliferating B cells

British journal of pharmacology, 2017-04, Vol.174 (8), p.628-640

2017

Volltextzugriff (PDF)

The role of the receptor tyrosine kinase, AXL, in metastatic endometrial cancer

Gynecologic oncology, 2015-10, Vol.139 (1), p.199-200

2015

Volltextzugriff (PDF)

The receptor tyrosine kinase discoidin domain receptor 2 promotes invasion via epithelial mesenchymal transition in ovarian cancer

Gynecologic oncology, 2015-10, Vol.139 (1), p.189-189

2015

Volltextzugriff (PDF)

Modelling and analysis of deep drawing with utilisation of vibrations and servo press using response surface methodology

Materials research innovations, 2014-05, Vol.18 (sup2), p.S2-936-S2-939

2014

Volltextzugriff (PDF)

080 Unraveling tumor microenvironment dynamics: Integrating GAS6/AXL signaling in cancer-associated fibroblasts and extracellular matrix deposition

Journal of investigative dermatology, 2024-08, Vol.144 (8), p.S15-S15

2024

Volltextzugriff (PDF)

Concomitant chemotherapy and radiation for the treatment of advanced-stage endometrial cancer

Gynecologic oncology, 2014-07, Vol.134 (1), p.24-28

2014

Volltextzugriff (PDF)

In vivo effects of targeting CD79b with antibodies and antibody-drug conjugates

Molecular cancer therapeutics, 2009-10, Vol.8 (10), p.2937-2946

2009

Volltextzugriff (PDF)

Every-three-week versus dose dense weekly paclitaxel neoadjuvant chemotherapy for advanced stage ovarian, fallopian tube, and peritoneal cancers

Gynecologic oncology, 2014-11, Vol.135 (2), p.383-383

2014

Volltextzugriff (PDF)

Immunoregulatory gene expression and response to bevacizumab in ovarian cancer — An analysis of the cancer genome atlas

Gynecologic oncology, 2012-10, Vol.127 (1), p.S15-S15

2012

Volltextzugriff (PDF)

Immune signatures predictive of optimal cytoreduction in ovarian cancer

Gynecologic oncology, 2012-03, Vol.125, p.S46-S46

2012

Volltextzugriff (PDF)

Immune biomarkers predictive of survival in epithelial ovarian cancer

Gynecologic oncology, 2012-03, Vol.125, p.S45-S46

2012

Volltextzugriff (PDF)

Immune biomarkers associated with response to intra-peritoneal chemotherapy in ovarian cancer

Gynecologic oncology, 2012-03, Vol.125, p.S141-S141

2012

Volltextzugriff (PDF)

The treatment and outcomes of early-stage epithelial ovarian cancer: have we made any progress?

British journal of cancer, 2008-04, Vol.98 (7), p.1191-1196

2008

Volltextzugriff (PDF)

Review article: nonclinical and clinical pharmacology, pharmacokinetics and pharmacodynamics of etrolizumab, an anti‐β7 integrin therapy for inflammatory bowel disease

Alimentary pharmacology & therapeutics, 2018-06, Vol.47 (11), p.1440-1452

2018

Volltextzugriff (PDF)

Evaluation and use of an anti‐cynomolgus monkey CD79b surrogate antibody–drug conjugate to enable clinical development of polatuzumab vedotin

British journal of pharmacology, 2019-10, Vol.176 (19), p.3805-3818

2019

Volltextzugriff (PDF)

Dielectric property measurement using a resonant nonradiative dielectric waveguide structure

IEEE microwave and wireless components letters, 2005-02, Vol.15 (2), p.104-106

2005

Volltextzugriff (PDF)

The mesenteric hemodynamic response to circulatory shock : An overview

Shock (Augusta, Ga.), 2001-05, Vol.15 (5), p.329-343

2001

Volltextzugriff (PDF)

The use of molecular markers to predict for optimal cytoreduction in ovarian cancer

Gynecologic oncology, 2012-03, Vol.125, p.S13-S13

2012

Volltextzugriff (PDF)

The use of molecular markers to predict for optimal cytoreduction in ovarian cancer

Gynecologic oncology, 2011-11, Vol.123 (2), p.436-437

2011

Volltextzugriff (PDF)

Exploiting Radiation Induced Anti-Tumor Immunity in Advanced-Stage and Metastatic Ovarian Cancer

International journal of radiation oncology, biology, physics, 2020-11, Vol.108 (3), p.e470-e470

2020

Volltextzugriff (PDF)

The impact of chemotherapy and fertility-sparing surgery on recurrence of serous borderline ovarian tumors: A multi-institutional study of 491 patients

Gynecologic oncology, 2012-03, Vol.125, p.S5-S5

2012

Volltextzugriff (PDF)

An economic analysis of bevacizumab in recurrent treatment of ovarian cancer

Gynecologic oncology, 2011-03, Vol.120, p.S29-S30

2011

Volltextzugriff (PDF)

Mesenteric vasoconstriction in response to hemorrhagic shock

Shock (Augusta, Ga.), 2000-04, Vol.13 (4), p.267-273

2000

Volltextzugriff (PDF)

1 – 25 von 612

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(547)
Mit Volltextzugriff
(554)

Publikationsform

Sprache

Englisch
(606)
Japanisch
(108)
Deutsch
(4)
Chinesisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(456)
Life Sciences & Biomedicine
(256)
Humans
(197)
Female
(140)
Technology
(133)
Male
(117)
Biological And Medical Sciences
(110)
Physical Sciences
(110)
Engineering
(107)
Exact Sciences And Technology
(87)
Middle Aged
(85)
Medical Sciences
(84)
Aged
(74)
Adult
(69)
Applied Sciences
(59)
Engineering, Manufacturing
(59)
Materials Science
(56)
Neurosciences & Neurology
(55)
Physics
(55)
Materials Science, Multidisciplinary
(53)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A fully packaged self-powered sensor based on near-field electrospun arrays of poly(vinylidene fluoride) nano/micro fibers

A fully encapsulated piezoelectric–triboelectric hybrid nanogenerator for energy harvesting from biomechanical and environmental sources

Anti‐CD22 and anti‐CD79b antibody‐drug conjugates preferentially target proliferating B cells

The role of the receptor tyrosine kinase, AXL, in metastatic endometrial cancer

The receptor tyrosine kinase discoidin domain receptor 2 promotes invasion via epithelial mesenchymal transition in ovarian cancer

Modelling and analysis of deep drawing with utilisation of vibrations and servo press using response surface methodology

080 Unraveling tumor microenvironment dynamics: Integrating GAS6/AXL signaling in cancer-associated fibroblasts and extracellular matrix deposition

Concomitant chemotherapy and radiation for the treatment of advanced-stage endometrial cancer

In vivo effects of targeting CD79b with antibodies and antibody-drug conjugates

Every-three-week versus dose dense weekly paclitaxel neoadjuvant chemotherapy for advanced stage ovarian, fallopian tube, and peritoneal cancers

Immunoregulatory gene expression and response to bevacizumab in ovarian cancer — An analysis of the cancer genome atlas

Immune signatures predictive of optimal cytoreduction in ovarian cancer

Immune biomarkers predictive of survival in epithelial ovarian cancer

Immune biomarkers associated with response to intra-peritoneal chemotherapy in ovarian cancer

The treatment and outcomes of early-stage epithelial ovarian cancer: have we made any progress?

Review article: nonclinical and clinical pharmacology, pharmacokinetics and pharmacodynamics of etrolizumab, an anti‐β7 integrin therapy for inflammatory bowel disease

Evaluation and use of an anti‐cynomolgus monkey CD79b surrogate antibody–drug conjugate to enable clinical development of polatuzumab vedotin

Dielectric property measurement using a resonant nonradiative dielectric waveguide structure

The mesenteric hemodynamic response to circulatory shock : An overview

The use of molecular markers to predict for optimal cytoreduction in ovarian cancer

The use of molecular markers to predict for optimal cytoreduction in ovarian cancer

Exploiting Radiation Induced Anti-Tumor Immunity in Advanced-Stage and Metastatic Ovarian Cancer

The impact of chemotherapy and fertility-sparing surgery on recurrence of serous borderline ovarian tumors: A multi-institutional study of 491 patients

An economic analysis of bevacizumab in recurrent treatment of ovarian cancer

Mesenteric vasoconstriction in response to hemorrhagic shock

Suchergebnisse filtern